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ABSTRACT 12 
Recently, it was suggested that curcumin is an irreversible inhibitor of rhodesain, a 13 
cathepsin L-like cysteine protease found in the lysosome of the protozoan parasite 14 
Trypanosoma brucei. However, dilution of rhodesain incubated with curcumin with 15 
curcumin free buffer resulted in an immediate recovery of enzymatic activity. This 16 
finding clearly demonstrates that curcumin is in fact a reversible inhibitor of rhodesain. 17 
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Dear Editor, 22 
 23 
I would like to comment on the article “Drug combination studies of curcumin and 24 
genistein against rhodesain of Trypanosoma brucei rhodesiense” by Ettari et al. 25 
(2018). In their article, the authors claim that curcumin and genistein are irreversible 26 
inhibitors of rhodesain (the major lysosomal cysteine protease of T. brucei) and that 27 
both compounds in combination act synergistically in inactivating the enzyme. 28 
However, it is not possible that two irreversible inhibitors can interact synergistically in 29 
inhibiting the activity of an enzyme. By definition, irreversible inhibitors chemically 30 
modify their target enzyme by reacting with the active-site amino acid residue. 31 
Accordingly, two compounds irreversibly inhibiting an enzyme cannot influence each 32 
other on their binding of the catalytic amino acid residue. This is only possible if one 33 
of the compounds binds the enzyme at a different site. Thus, the binding of one 34 
compound could increase the affinity for the other compound and vice versa resulting 35 
in a synergetic effect of the combination of the two compounds. 36 
The evidence provided by the authors to support that curcumin and genistein are 37 
irreversible inhibitors of rhodesain are unconvincing. The irreversible inhibition of the 38 
compounds were based (i) on a time-dependent loss of enzyme activity and (ii) on the 39 
lack of recovery of enzymatic activity after dilution. However, the time-dependent 40 
inhibition was only marginal and the enzyme was never completely inhibited, even at 41 
higher inhibitor concentrations. Likewise, the dilution factor in the dilution experiment 42 
was minimal (only 1:2), so that the final inhibitor concentration was still very high. In 43 
the case of genistein, the high IC50 value (500 µM) observed for the inhibition of 44 
rhodesain activity is quite unusual for an irreversible inhibitor. Generally, irreversible 45 
inhibitors of T. brucei cysteine proteases have IC50 values below 1 µM and those with 46 
IC50 values > 100 µM are usually considered inactive (Steverding et al. 20112). 47 
The lack of convincing evidence whether curcumin and genistein are irreversible 48 
inhibitors of rhodesain prompted me to perform own experiments. Based on available 49 
reagents, I carried out dilution experiments with curcumin (Figure 1). Incubation of 50 
4 
 
rhodesain with 10 µM curcumin resulted in an enzymatic rate of 2.74 RFU/min. When 51 
the reaction mixture was diluted 1:4 with measuring buffer containing 10 µM curcumin, 52 
the enzymatic rate dropped to 0.74 RFU/min, which was 27% of the activity before 53 
dilution and thus in agreement with an one in four dilution of the amount of enzyme 54 
(the expected activity would have been 25%). In contrast, when the reaction mixture 55 
was diluted 1:4 with measuring buffer lacking curcumin, the enzymatic rate increased 56 
to 12.82 RFU/min, which was 4.68 and 17.32 times higher compared with the starting 57 
mixture and after dilution in the presence of 10 µM curcumin, respectively. Were 58 
curcumin an irreversible inhibitor of rhodesain, no difference in the enzymatic rate 59 
between the dilution in the presence and absence of 10 µM curcumin would be 60 
expected. As the enzymatic rate after dilution in curcumin free measuring buffer 61 
increased substantially (despite a 4-fold reduction in enzyme concentration), thus it 62 
can be concluded that curcumin is a reversible inhibitor of rhodesain and not an 63 
irreversible one. 64 
The lesson, here, is: in order to determine the mode of action of inhibitors, one 65 
needs to carry out the right experiments and to interpret the obtained data correctly. 66 
The best way to do this would be to perform rigorous kinetic enzyme analysis. 67 
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Figure Legends 89 
Figure 1. Reversibility of curcumin inhibition on rhodesain. Rhodesain (67 ng) was 90 
incubated in measuring buffer (100 mM citrate, pH 5.0, 2 mM DTT and 10 µM 91 
benzyloxycarbonyl-phenylalanyl-arginyl-7-amido-4-methyl coumarin (Z-FR-AMC) as 92 
fluorogenic substrate) in the presence of 10 µM curcumin in a final volume of 2 ml at 93 
room temperature. The release of 7-amino-4-methylcoumarin (AMC) was recorded 94 
with a BIORAD VersaFluor fluorometer using excitation and emission wavelengths of 95 
360 nm and 460 nm every min (triangles). After 20 min incubation, the reaction mixture 96 
was diluted 1:4 with measuring buffer either containing 10 µM curcumin (squares) or 97 
the equivalent amount of DMSO (circles), and release of AMC was continued to be 98 
recorded. Note that the drop in RFU after dilution with measuring buffer containing 10 99 
µM curcumin is due to the dilution of released AMC. Note that the increase in RFU 100 
after dilution with measuring buffer lacking curcumin is due to the fact that curcumin 101 
shifts RFU into negative values. Therefore, by diluting curcumin containing buffer with 102 
curcumin free buffer, RFU increases. RFU, relative fluorescence unit. 103 
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Figure 1 105 
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